RNA-targeting CRISPR-Cas13 Provides Broad-spectrum Phage Immunity
B. A. Adler, T. Hessler, B. F. Cress, V. K. Mutalik, R. K. Barrangou, J. Banfield, J. A. Doudna
This paper demonstrates that LbuCas13a can broadly inhibit diverse E. coli phages and enable efficient, markerless phage genome editing.
bioRxiv · Mar 25, 2022 · PreprintMicrobiology